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this subject with conflicting speculations regarding the 
clinical effectiveness of metaphor use within healthcare. 
No systematic reviews have been conducted to explore if 
metaphors have therapeutic value for people in pain. 
Summary of existing literature
A lack of quantitative studies exists with few RCTs.  A range 
of qualitative work has been conducted with encouraging 
findings for metaphor use within healthcare. However, most 
studies are opinion-based.  No systematic reviews have been 
conducted regarding metaphors and pain.  Considering the 
demand of the global pain epidemic and the well-documented 
challenges facing both people in pain and healthcare 
professionals, it is essential to develop our understanding of 
metaphor’s value within clinical practice.
Research Question
1.  Do metaphors have therapeutic value for people in 
pain?
Aims
1.  To review the evidence for the potential therapeutic 
use of metaphors within pain management.
2.  To explore current treatment approaches
3.  To guide future research interests.
Search strategy
Medline, Cochrane, One Search, PsycNET, Science Direct 
and Prospero.
Methodology
Meta-ethnography to synthesise qualitative studies.
Quality Assessment
Critical Appraisal Skills Programme (CASP) checklist for 
qualitative research (2006).
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Abstract
Design. A case-control feasibility study, comparing people with 
unilateral shoulder pain and pain free controls. Background. 
Previous studies have suggested that central sensitisation (CS) 
may be present in people with shoulder pain, mostly based on 
testing of nociception rather than mechanosensitivity, both of 
which can change as part of CS. Changes in mechanosensitivity 
are important for physiotherapy, which often involves non-
noxious mechanoreceptor stimulation. Objectives. This study 
tested sensitivity to a range of mechanical stimuli potentially 
associated with CS in people with shoulder pain, compared 
to asymptomatic individuals. It was hypothesised that if CS 
was present, the response to mechanoreceptor stimulation 
would be increased. Methods. Both shoulders in both groups 
were tested for sensitivity of static and dynamic touch, 
vibration and punctate stimulation, plus temporal summation 
and pressure pain threshold (PPT). Participants completed 
a demographic questionnaire, pain scales, PainDETECT for 
neuropathic pain, and QuickDASH for upper limb function. 
Results. PPT was found to be significantly lower in the affected 
compared to the unaffected shoulders (p<0.003), but no 
other statistically significant between-group differences were 
found. Conclusion. This study found a lowered PPT in people 
with unilateral shoulder pain compared with asymptomatic 
individuals, but no evidence of a heightened response to other 
forms of mechanoreceptor stimulation. The study protocol 
FEATURES OF CENTRAL 
SENSITISATION IN PATIENTS 
WITH SHOULDER PAIN – A 
FEASIBILITY STUDY
was suitable for future studies and the required participant 
numbers were established. The variation in findings between 
studies suggests that a larger longitudinal study may be 
warranted.
Keywords: Central sensitisation, Shoulder pain, Sensory 
testing, Mechanosensitivity
Introduction
Central sensitisation (CS) is defined by the International 
Association for the Study of Pain (IASP) as an “increased 
responsiveness of nociceptive neurons in the central nervous 
system to their normal or sub threshold afferent input” 1. 
It is not possible to establish CS or its exact mechanism in 
humans, so it is important to use the term only tentatively in 
clinical contexts 2. That said, recent reviews have suggested 
that CS may play a role in persistent shoulder pain 3, 4.  Studies 
included in these reviews found a range of painful shoulder 
issues to be associated with a reduced pressure pain threshold, 
a heightened sensitivity to punctate mechanical stimuli, 
a reduction in conditioned pain modulation (CPM) and a 
heightened response to noxious heat 5-9.
Neurophysiological research has demonstrated several 
segmental changes in the processing of nociceptive, as well 
as non-nociceptive, stimuli in the central nervous system. CS 
is thought to be associated with allodynia, mediated by low-
threshold mechanoreceptors and Aß afferents 10, 11. Another 
manifestation of CS is hyperalgesia, which occurs in response 
to noxious punctate or sharp stimuli, thought mainly to be 
mediated by nociceptive Aß afferents 11, 12. Enhanced central 
processing may in addition facilitate temporal summation, a 
gradually increasing response to repeated stimulation 13.
Many physiotherapy treatments for pain involve non-noxious 
mechanical stimuli, which have not been investigated in detail 
in previous studies of CS in people with shoulder pain. It 
is important for healthcare professionals to know whether 
an apparent exaggerated response to mechanoreceptor 
stimulation could be the result of CS. This study therefore set 
out to investigate sensitivity to a number of mechanical stimuli 
that might be associated with CS: comparing individuals with 
unilateral shoulder pain with asymptomatic individuals. We 
hypothesised that if CS was present in patients with shoulder 
pain, the response to mechanoreceptor stimulation might 
be heightened. We also wanted to determine participant 
numbers required to establish between-group differences and 
to test the protocol for use in a larger investigation.
Materials and methods
Approvals
Ethics approval was obtained from the University of 
Hertfordshire Health and Human Sciences Ethics Committee 
with Delegated Authority, protocol number HSK/SF/
UH/02716.
Participants
Participants had to have unilateral pain in the deltoid region 
of the shoulder of at least 3 months’ duration, rated as 
4/10 or more at least some of the time. The study’s focus 
was on pain and sensory changes and most participants 
were a convenience sample of workers at the University 
of Hertfordshire rather than patients’ attending a clinic, 
so no attempt was made to gather diagnostic information. 
The control group had to be asymptomatic at the shoulder. 
All participants had to be at least 18 years of age. Exclusion 
criteria were other pain problems present for more than 
3 months, with pain rated as regularly greater than 4/10; 
scarring, lesions or numbness in the region to be tested; 
inability or unwillingness to bilaterally expose the deltoid 
region of the shoulder; concurrent neck pain.
All participants were recruited by emailing staff at the 
University of Hertfordshire in February 2017. Members of 
staff who expressed an interest in taking part in the study 
were sent information and a consent form. Some members 
of staff forwarded the email to relatives, who were sent the 
documents once they contacted the researcher. Following 
informed written consent, which permitted withdrawal at 
any time without the need to explain, participants were asked 
to complete a set of questionnaires and attend for sensory 
testing of both shoulders. As suggested by Hertzog 14, a 
minimum of 15 participants per group were recruited for this 
feasibility study.
Questionnaires
Participants were asked to complete a demographics 
questionnaire. The PainDETECT questionnaire was used 
to assess the likelihood of a neuropathic pain component15. 
Subjective pain and pain-related distress, both current 
and average, were assessed with numerical rating scales16. 
The QuickDASH questionnaire, an 11-item version of the 
longer 30 item Disabilities of the Arm, Shoulder and Hand 
questionnaire (DASH), was used to assess function of the 
upper limb17.
Sensory testing
Sensitivity to a range of mechanical sensory stimuli were 
tested; specifically sensitivity to dynamic mechanical touch 
and punctate stimulation, as well as temporal summation. One 
nociceptive mechanical stimulus was included, pressure pain 
threshold (PPT), because it had been tested in several studies 
that suggested the presence of CS in people with shoulder 
pain. Perception threshold to static mechanical touch and 
vibration were also examined.
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No participants were found to have a definite neuropathic 
component to their pain based on their PainDETECT scores. 
Pain and pain-related distress, both average and current, 
showed wide variation in the group with shoulder pain 
(Table 2). 
Mean QuickDASH scores were 0.36 (SD 0.89) for 
asymptomatic participants and 17.25 (SD 18.60) for 
participants with shoulder pain, with 2 scores missing from 
the pain group (Table 2). All participants allowed all tests to 
be performed, but equipment failure meant that PPT could 
not be tested in 2 participants with pain and 2 without pain.
Table 3 details the results of sensory testing of perception 
threshold for static light touch, sensitivity to vibration, PPT 
and temporal summation, comparing painful shoulders with 
all shoulders in the control group. Table 4 details the results 
for unaffected shoulders versus all shoulders in the control 
group. Results in both tables are presented as a mean (range). 
None of the raw data were normally distributed initially, so 
a Log10 transformation was applied to sensory perception 
threshold, vibration and PPT. A square root transformation 
was applied to temporal summation, in order not to negate 
zero difference. Independent t-tests compared the means 
between both groups for all tests except vibration, for which 
a Mann-Whitney test was performed because of non-normal 
distribution after transformation. For the feasibility aspect 
of the study, the sample size estimations were performed in 
G*Power (version 3.1.9.4) based on the calculated effect 
sizes, assuming a two-sided 80% power and a 5% significance 
level using the t-test.
No statistically significant differences between groups were 
established for sensitivity to static or dynamic touch, vibration, 
punctate stimulation or temporal summation. Only PPT in the 
painful shoulder was statistically significantly lower than PPT 
in the control group. Although PPT in unaffected shoulders in 
participants with shoulder pain was also lowered, this did not 
reach significance following Bonferroni correction. The study 
protocol was easy to apply in under 20 minutes.
Discussion
This study found that participants with unilateral shoulder 
pain had a significantly lower PPT over the deltoid muscle 
Sensory testing took place in a single room by the first 
author, using a single set of devices. The tests were applied 
as described by Rolke et al.18 in the following standard order. 
Static mechanical perception threshold was tested using 
calibrated fibreglass Marstock Nervtest von Frey filaments. 
A wisp of cotton wool, a cotton wool bud on a light spring 
and a Somedic SENSELab Brush-05 were applied in this order 
to test pain sensitivity to dynamic light touch. Detection 
threshold for vibration was determined with a Rydell-Seiffer 
64Hz calibrated tuning fork. A 256mN von Frey filament was 
used to determine sensitivity to punctate mechanical stimuli. 
Temporal summation was assessed by comparing the rating 
of a single 256mNvon Frey filament with the rating at the 
end of 10 repetitions of one per second. Finally, PPT was 
determined with a Wagner FPX pressure algometer with an 
applicator of 1cm2. In participants with shoulder pain, the 
non-painful side was tested first. Vibration was tested on the 
centre of the lateral border of the acromion; all other tests 
were applied over and around the centre of the deltoid region. 
Finally, time taken for the testing procedure was noted for 
future studies.
Statistical Analysis
Data were analysed using IBM SPSS version 25. Statistical 
analysis was undertaken using the independent t-test to 
compare the sensory characteristics between the participants 
with shoulder pain and the control group. The statistical 
significance threshold was set to p=0.05. Bonferroni p-value 
correction was applied because the control group data was 
used twice, with the adjusted p<0.0167 indicating statistical 
significance.
Results
Thirty-nine participants took part in the study. Eighteen 
had unilateral pain in the deltoid region of the shoulder and 
21 did not have any shoulder symptoms. One participant 
was excluded from analysis because their pain was felt only 
over the medial border of the scapula. Table 1 details the 
demographic information.
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TABLE 1. Age and gender distribution of participants
Control n=21 
Female=14; Male=7 
All white
All employed
Shoulder pain n=17
Female=15; Male=2
White;
1 mixed race female
Employed; 1 pensioner
Age 30-39 8 2
Age 40-49 4 3
Age 50-59 7 7
Age 60+ 2 3
Missing - 2
TABLE 2. QuickDASH and pain scores (mean, SD)
QuickDASH Pain 
Current
Pain 
Average
Distress 
Current
Distress 
Average
Shoulder 
pain group
17.25 
(18.6)
2.5 
(2.34)
5 (2.56) 2.5 
(2.00)
3.5 
(2.18)
Control 
group
0.36 (0.9) 0 (0) 0 (0) 0 (0) 0 (0)
on the symptomatic side, compared with asymptomatic 
individuals. This is in line with findings by most previous 
authors, with the exception of one study which found a higher 
rather than a lower PPT threshold 19. The current study tested 
for additional regional sensory changes associated with CS 
such as allodynia to stroking, sensitivity to punctate stimuli 
and temporal summation, and found no statistical difference 
between groups.  Recent studies have failed to find temporal 
summation to repeated pinprick 19, 20, or a significantly lowered 
PPT 20, or vibration detection threshold 20. Moreover, they 
found no evidence of changes in conditioned pain modulation 
or sensitivity at a distance from the shoulder 19, 20.
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TABLE 3. Results for painful shoulder vs both shoulders in control group
Shoulder 
pain group- 
affected 
shoulder
Control 
group
Test statistic p-value Effect size Power Sample size 
required to 
differentiate 
(control 
group / pain 
group)
Log of 
sensory 
threshold 
mean
0.668 
(0.41 to 0.97)
0.646 
(0.36 to 0.87)
0.676 0.50 0.19 0.102 625 / 313
Log of 
vibration 
mean
0.861 
(0.8 to 0.9)
0.876 
(0.8 to 0.9)
0.992 0.321 0.453 0.328 123 / 61
Log of PPT 
mean
1.259 
(0.98 to 1.65)
1.409 
(1.07 to 1.70)
3.12 0.003* 0.963 0.867 28 / 14
Square root 
of temporal 
summation 
difference 
mean
2.605 
(0 to 7.07)
1.917 
(0 to 7.62)
1.156 0.248 0.343 0.328 211 / 105
*  statistically significant
TABLE 4. Results for unaffected shoulder in shoulder pain group vs both shoulders in control group
Shoulder 
pain group- 
affected 
shoulder
Control 
group
Test statistic p-value Effect size Power Sample size 
required to 
differentiate 
(power = 
0.8)
(control 
group / pain 
group)
Log of 
sensory 
threshold 
mean
0.6772 
(0.53 to 1)
0.646 
(0.36 to 0.87)
0.962 0.34 0.276 0.157 311 / 155
Log of 
vibration 
mean
0.866 
(0.8 to 0.9)
0.876 
(0.8 to 0.9)
0.983 0.326 0.322 0.19 240 / 120
Log of PPT 
mean
1.301
(1.15 to 1.56)
1.409 
(1.07 to 1.70)
2.44 0.018 0.75 0.667 44 / 22
Square root 
of temporal 
summation 
difference 
mean
2.26
(0 to 5.2)
1.917 
(0 to 7.62)
0.837 0.402 0.183 0.094 740 / 370
2. Respecting this uncertainty, we recommend cautious use of 
language when explaining the nature of symptoms to patients 
with shoulder pain. The variation in findings between studies 
and the fact that CS may be an adaptive mechanism, suggest 
that a larger longitudinal study may be warranted.
Limitations
This was a feasibility study involving only a small number 
of participants, nearly all of whom were white British or 
European, so results may not apply beyond these groups. 
Although participants with neck pain were excluded and 
no participants had neuropathic pain according to their 
PainDETECT scores, participants were not examined to 
exclude a potential cervical origin of their shoulder pain. We 
also acknowledge the limitations of using the PainDETECT 
questionnaire to rule out neuropathic pain in the upper 
limb. Symptoms may not have been as severe as in studies 
investigating people seeking treatment5, 6, 8, which may have 
had implications for our findings. Demographic information 
and QuickDASH were missing for 2 participants and PPT 
could not be tested for 4 participants (2 with shoulder pain 
and 2 without), reducing the available datasets. It is possible 
that there is a time-dependent component to CS, which may 
be more pronounced as pain persists. One participant was 
made aware of the study by a relative who took part, with 
potential for bias. No tests were conducted for signs of altered 
sensitivity at sites remote from the shoulders. These issues 
must be addressed in a larger future study.
Conclusion
This feasibility study investigated the presence of a range of 
sensory changes associated with CS, comparing people with 
and without shoulder pain. Evidence of alterations in PPT were 
found on both sides in people with unilateral shoulder pain, 
which reached significance on the affected side. No other sensory 
differences were established. It is likely that CS is an adaptive 
phenomenon which changes over time. This and the fact that 
the findings of different researchers have varied, suggests that 
a larger longitudinal study investigating sensitisation in a larger 
group of participants with  shoulder pain may be warranted. 
This study prepared the ground for such an investigation by 
testing the protocol and establishing the participant numbers 
required for detection of differences in PPT.
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The feasibility aspect of this study established participant 
numbers required to establish differences in sensory 
modalities between participants with and without shoulder 
pain. The application time of under 20 minutes suggests that 
additional testing of sensitivity at distant sites may be feasible.
Diagnosis of shoulder pain
Diagnosing the source of shoulder pain is complex and may 
not always be possible with confidence, either clinically 
or radiologically 21-26. In addition to clinical structural and 
radiological diagnoses, hyperexcitability of the CNS has 
been purported as an explanation for pain experienced by 
some individuals with unilateral shoulder pain, as well as 
poor surgical outcomes8. However, these outcomes may in 
part relate to the uncertainty of  diagnostic labels such as 
subacromial impingement syndrome 24, 25, the appropriateness 
of certain  surgical interventions 25, 27, and the small number of 
participants in the studies. We therefore recommend caution 
when interpreting published findings and translating them 
into clinical practice.
It is important for clinicians to appreciate that our understanding 
of the role of CS in a shoulder pain population is still in its 
infancy4. We agree with recent authors that it is important 
for clinicians to recognise signs of CS in their patients 28, 29, 
but to be mindful that CS cannot be demonstrated clinically 
2. Moreover, changes in sensory processing in patients with 
shoulder pain may be no more than a temporary adaptation 
to pain31. This would be entirely in line with the nervous 
system as a system for gathering and evaluating information, 
and generating appropriate responses 32, 33. To improve the 
efficacy of physiotherapy, strategies designed to enhance 
central inhibitory mechanisms could be coupled with other 
therapeutic approaches34, 35.
Terminology
It is possible that CS in people experiencing shoulder pain 
may have been over reported due to a confusion over the 
definition of the term. CS and its manifestations have been 
defined using various terminology, which differs from the 
IASP definition. One paper defines CS as an amplification of 
neural signalling within the central nervous system (CNS) that elicits 
pain hypersensitivity4, citing an operational definition by Woolf 
36, while Woolf himself has since endorsed the IASP definition 
37. Other authors refer to CS as altered neural thresholds in the 
spinal cord and/or reduced cortical inhibition of pain3, or avoid the 
term in favour of the term central hypersensitivity, an augmentation 
of the nociceptive pathways of the central nervous system5. It may be 
necessary to reach a consensus on when to use the term CS 
and the terminology we use to define it. Most importantly, 
one should be aware that CS cannot be demonstrated in vivo, 
so clinical findings can be attributed to CS only hypothetically 
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